Description
Parteck® M 100 excipient is part of the Parteck® range of functional excipients developed specifically for solid dose applications. It is a directly compressible mannitol with excellent compressibility which keeps the API stable and enables rapid disintegration and fast dissolution. As Emprove® Essential excipient, it is a high quality pharmaceutical excipient, offered with extensive documentation facilitating compliance, full supply chain transparency and risk mitigation.
The directly compressible mannitol Parteck® M is a good choice for rapid release of high-dose or low-dose active pharmaceutical ingredients (APIs). Developed under Merck’s advanced Functional Particle Engineering concept, it is available in two different particle size distributions: Parteck® M 100 and Parteck® M 200.
Benefits of Parteck® M:
- High compactibility at low compression forces
- Rapid disintegration and fast dissolution
- High dilution potential
- Non-hygroscopic, exceptionally low content of reducing sugars
- Emprove® documentation and regulatory support
Unique Particle Structure
With its unique particle structure, Parteck® M mannitol allows you to press robust, high-quality tablets with direct compression – no need for prior granulation steps. It is also suitable for low-dose formulation where dose uniformity and mix homogeneity are crucial.














































